Profil
Martin Brena is currently a Director at Actinobac Biomed, Inc., 1200 Pharma LLC, Pinpoint Therapeutics, Inc., and an Investment Associate at Kairos Venture Investments LLC.
He previously worked as a Director at Actuate Therapeutics, Inc. from 2021 to 2023.
Mr. Brena received his undergraduate degree from Ohio Wesleyan University and his MBA from UCLA Anderson School of Management.
Aktive Positionen von Martin Brena
| Unternehmen | Position | Beginn |
|---|---|---|
Kairos Venture Investments LLC
Kairos Venture Investments LLC Investment ManagersFinance Kairos Ventures invests in companies located in the United States. The firm focuses on life sciences, physical sciences, and technology sector. It provides financing for early-stage capital requirements with an investment size of USD 0.15 - USD 20 million. | Private-Equity-Analyst | 01.01.2021 |
Pinpoint Therapeutics, Inc.
Pinpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for cancer treatments | Direktor/Vorstandsmitglied | 01.04.2022 |
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technologies | Direktor/Vorstandsmitglied | 01.02.2022 |
1200 Pharma LLC
1200 Pharma LLC Pharmaceuticals: MajorHealth Technology Provides pre-clinical drug discovery and clinical approval services | Direktor/Vorstandsmitglied | 01.01.2021 |
Ehemalige bekannte Positionen von Martin Brena
| Unternehmen | Position | Ende |
|---|---|---|
| ACTUATE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.03.2023 |
Ausbildung von Martin Brena
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Ohio Wesleyan University
Ohio Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technologies | Health Technology |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
Kairos Venture Investments LLC
Kairos Venture Investments LLC Investment ManagersFinance Kairos Ventures invests in companies located in the United States. The firm focuses on life sciences, physical sciences, and technology sector. It provides financing for early-stage capital requirements with an investment size of USD 0.15 - USD 20 million. | Finance |
1200 Pharma LLC
1200 Pharma LLC Pharmaceuticals: MajorHealth Technology Provides pre-clinical drug discovery and clinical approval services | Health Technology |
Pinpoint Therapeutics, Inc.
Pinpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for cancer treatments | Health Technology |
















